Corvus Pharmaceuticals (CRVS)Director sold ~$4.89M
Peter A. Thompson, Director at Corvus Pharmaceuticals, sold ~$4.89M of Corvus Pharmaceuticals shares.
- ~$4.89M
- Approx. value · 1.18M sh @ $4.16
- 7.17M
- Holds after · shares reported
- Traded
- Jun 27, 2025
- Filed
- Jul 2, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jun 27, 2025 · this disclosureInsiderDirector sold ~$4.89M of CRVS shares in the open market
What came next
- Jun 27, 2025InsiderDirector sold ~$4.89M of CRVS shares in the open market
- Oct 2, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 2, 2025, the Board of Directors (the “Board”) of Corvus Pharmaceuticals, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee (the “Nominating Committee”), appointed David Moore to the Board.”
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Corvus Pharmaceuticals
For Corvus Pharmaceuticals, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CRVS page.
Other recent filings by Peter A. Thompson, Director
- SEC Form 4 at Edgewise Therapeutics (EWTX)Apr 4, 2025
- SEC Form 4 at Edgewise Therapeutics (EWTX)Apr 4, 2025
- SEC Form 4 at Sionna Therapeutics (SION)Feb 10, 2025
The full history of Peter A. Thompson, Director is on the profile page.
How this filing works
Other disclosures at Corvus Pharmaceuticals
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRMay 29, 2026
- SEC Form 13F-HRMay 15, 2026
- SEC Form 13F-HRFeb 17, 2026
- SEC Form 13F-HRAug 14, 2025
- SEC Form 4Jul 2, 2025
Everything OQRO holds on this company is on its CRVS page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data